Get the latest insights with syndromic testing webinars

Title: Utility of syndromic testing with direct nasopharyngeal swab samples in the diagnosis of viral respiratory infections in children

Speaker: Danilo Buonsenso, MD, PhD, Department of Woman and Child Health and Public Health, Gemelli University Hospital, Italy

Syndromic respiratory panels used in combination with direct nasopharyngeal swabs offer a rapid and non-invasive way to detect a multitude of respiratory pathogens simultaneously. Join Dr. Danilo Buonsenso as he delves into the world of syndromic respiratory panels, revealing how they can revolutionize the care of hospitalized children battling fever and/or respiratory symptoms. He'll share his firsthand experiences with this cutting-edge technology and guide us through the latest clinical trials and studies.

Title: Clinical impact of using syndromic testing for meningitis and encephalitis

Speaker: Xiaohui Nielsen, MD, PhD, Department of Clinical Microbiology, Zealand University Hospital, Denmark

Meningitis and encephalitis (M/E) result in considerable morbidity and mortality. Timely and accurate diagnosis is crucial for managing these infections. M/E syndromic panels are fast tests that can quickly identify a wide range of pathogens that cause M/E. Join Dr. Xiaohui Nielsen as she delves into published data and discusses her own experiences working with M/E panels. She walks through the benefits and caveats of these tests and approaches to clinical interpretation, and explains why her lab switched to the QIAstat-Dx Meningitis/Encephalitis Panel.

Title: Multiplex versus low-plex testing for infectious illness – could you be underdiagnosing patients?

Speaker: Carmen Miravet Zaragoza, MSc Medical Science Liaison, Medical and Scientific Affairs, QIAGEN

Does low-plex PCR testing really contribute to the underdiagnosis of respiratory infections? And if so, by how much? Join Carmen Miravet as she presents a recent study comparing results from a theoretical low-plex viral respiratory assay with the multiplex QIAstat-Dx Respiratory SARS-CoV-2 Panel. She discusses how epidemiology analyses like this could help influence your diagnostic approach.

Title: How and why you should move from culture testing to a rapid, 1-step multiplex RT-PCR test for acute diarrhea

Speaker: Prof. Laurence Armand-Lefevre, University of Paris Cité & Bichat-Claude Bernard Hospital

Gastroenteritis is a leading cause of medical consultation and sometimes requires hospitalization. Microbiological diagnosis is essential for managing these illnesses, but they're under-diagnosed due to inefficient, low-sensitivity testing. Join Prof. Laurence Armand-Lefevre to hear how multiplex RT-PCR with QIAstat-Dx can help improve the diagnosis of gastroenteritis. You’ll learn about the performance and benefits of multiplex RT-PCR for gastroenteritis, the impact on patient care and the management of outbreaks and practical tips for bringing this molecular technique to your lab.

Title: Leveraging rapid multiplex testing during the height of respiratory season

Speaker: Anooj Shah, PharmD, MBA, BCIDP, Medical Science Liaison, Infectious Diseases, QIAGEN

Multiplex diagnostic testing increases opportunities for the detection of respiratory pathogens and can help avoid misdiagnosis due to overlapping clinical symptoms. By eliminating diagnostic uncertainty, these tests can help healthcare practitioners decide when to start or stop antimicrobial therapy with more confidence. Join Dr. Shah for this webinar as he walks through the benefits of multiplex diagnostic testing. He’ll focus on the unique benefits offered by the QIAstat-Dx multiplex diagnostic system, including real-time epidemiology tracking.

Title: Rapid multiplex PCR diagnosis for viral respiratory infections in patients with respiratory distress syndrome using an innovative higher-throughput instrument

Speaker: Pr. Jérôme Le Goff, Professor of Virology at the Medicine Faculty of Université Paris Cité Saint-Louis Hospital, Paris, France

Patients admitted to the ICU for respiratory distress syndrome have a higher risk of mechanical ventilation and death if they present with a viral infection at admission. Quickly detecting respiratory viruses in this patient population could help identify those at higher risk of complications. Join Pr. Jérôme Le Goff as he discusses a study from his hospital assessing the impact of using an automated multiplex PCR system, the QIAstat-Dx Rise, for patients admitted to the ICU for acute distress syndrome.

Title: Impact of antimicrobial stewardship intervention in conjunction with rapid multiplex respiratory diagnostics

Speaker: Eric Wenzler, PharmD, BCPS, BCIDP, AAHIVP, Department of Pharmacy Practice, University of Illinois, Chicago College of Pharmacy, USA

Quickly distinguishing between viral and bacterial causes of respiratory illness can lead to optimized antibacterial and antiviral use and assist with decisions on hospital admission and infection control. In this webinar, Dr. Wenzler explains how multiplex respiratory panels can enable quick and definitive pathogen identification to support antimicrobial stewardship efforts and optimize clinical and economic outcomes.

Title: Improved diagnosis of gastrointestinal infections with a rapid PCR panel test
Speaker: Pierre Lureau Ph.D. Medical Director, Medical Biology Laboratory, Hospital Center of Niort, France

Acute gastrointestinal (GI) infections are strikingly common. Worldwide, there are over 2 billion cases every year. Correctly diagnosing these infections can help healthcare providers deliver timely and efficient care. In this webinar, Pierre Lureau Ph.D., director of the Medical Biology Laboratory at the Hospital Center of Niort in Deux-Sèvres, France, explains how the QIAstat-Dx Gastrointestinal Panel has improved GI diagnostics at his institution. He describes how the panel has simplified the laboratory’s GI testing workflow, increased the detection of pathogens and improved medical services for in and outpatients.

Syndromic panels for quick and effective diagnosis of meningitis and gastroenteritis
Speaker:Liliana Gabrielli, M.D., Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy

When a patient is critically ill, a quick diagnosis is crucial. New multiplex molecular tools have the potential to speed up the timely and effective delivery of therapeutics. But how do these sensitive and specific multiplex tools compare to routine diagnostic approaches, like singleplex real-time PCR? In this webinar, Dr. Liliana Gabrielli evaluates the potential performance of rapid molecular syndromic testing for the etiological diagnosis of central nervous system and gastrointestinal infections.

Title: Quickly diagnosing meningitis/encephalitis: Clinical validation of a rapid multiplex PCR panel test
Speaker: Thomas Sundelin Ph.D. Clinical Microbiology Department, Herlev Hospital, Denmark

Infections of the central nervous system (CNS) – meningitis and encephalitis – require immediate medical attention. Recent publications indicate that incorporating rapid multiplex PCR panel testing can speed up the time-to-diagnosis for CNS infections. In this webinar, Dr. Thomas Sundelin from the Clinical Microbiology Department at Herlev Hospital in Denmark discusses the clinical validation of QIAGEN’s rapid multiplex PCR test for CNS infections, the QIAstat-Dx Meningitis/Encephalitis Panel.

Title: Looking in the crystal ball: What will influenza-like illness season potentially look like post-COVID-19
pandemic?
Speaker: Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USA

The COVID-19 pandemic has dramatically changed the way influenza-like illnesses are diagnosed and managed. In addition, the seasonality of respiratory pathogens has shifted, making it difficult to predict future respiratory seasons. In this webinar, Dr. Roy F. Chemaly of MD Anderson Cancer Center discusses the impact of the pandemic on the incidence of respiratory viruses. He also explains how the diagnostic tools used to detect these viruses has evolved, and why a comprehensive diagnostic approach is crucial going forward, especially for immunocompromised patients.

Title: How is syndromic testing currently being used in the clinic and how will it impact diagnostics going forward?

Panel host: Davide Manissero, MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN

Panel members: Stephan Gehring, Prof Dr Med, Children’s Hospital Universitätsmedizin Mainz, Germany Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USA Susan A. Weaver, PhD, CLS, Natividad Medical Center, USA

As SARS-CoV-2 approaches endemic status, it will become increasingly important to quickly distinguish COVID-19 from other influenza-like illnesses. Multiplex PCR panel tests can detect and differentiate multiple pathogens at once. But how are these tests currently being used in the clinic and how will they impact diagnostics going forward? In this panel discussion, join three experts in infectious diseases as they discuss their personal experiences using multiplex testing and address pressing questions about this diagnostic approach.

Title: The clinical outcomes of using dry swabs for respiratory syndromic testing 
Speaker: Donia Bouzid, MD, PhD, Bichat Claude-Bernard Hospital, Emergency Department, France

This webinar discusses how multiplex syndromic testing using dry swab samples has positively impacted clinical decision making in a hospital in Paris, France. Dr. Donia Bouzid describes how prior to adopting multiplex PCR, Bichat Claude-Bernard Hospital experienced long wait times between the arrival of patients at the hospital and the diagnosis of respiratory infections. She then discusses how the faster turnaround time and comprehensive results provided by syndromic testing with the QIAstat-Dx Analyzer have influenced clinical outcomes at the hospital, including positively impacting single room assignment.

Title: Tackling COVID-19 through syndromic testing – QIAstat-Dx Respiratory SARS-CoV-2
Speaker: Davide Manissero, MD, MRCPCH, MSc, DTM&H, VP Head of Medical Affairs & Chief Medical Officer, Infection & Immune Diagnostics, QIAGEN

During this webinar, QIAGEN Chief Medical Officer Dr. Davide Manissero will discuss the role of multiplex respiratory PCR testing in the ongoing COVID-19 pandemic and how QIAGEN ramped up development efforts to be the first syndromic solution on the market. The importance of time to diagnosis and potential for co-infections as we approach the 2020-2021 influenza season will be discussed.

Title: A new multiplex syndromic system for respiratory diagnosis and improved patient care
Speaker: Dr. Steve Young, Director of Research and Clinical Trials, TriCore Reference Laboratories

This webinar discusses how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections. Acute respiratory tract infections are caused by a wide range of viral and bacterial pathogens and may share similar clinical presentations that make it difficult for physicians to diagnose based on symptoms alone. Syndromic testing with multiplex molecular panels offers clinical labs a way to quickly distinguish between a broad array of respiratory pathogens. In this webinar, Dr. Steve Young of Tricore Reference Laboratories presents a new technology for multiplexed respiratory testing in acutely ill patients. He shares data demonstrating the capabilities of syndromic respiratory testing as well as his impressions on the ease of doing comprehensive syndromic testing using the QIAstat-Dx Analyzer.